Prevalence and Description of High-Grade Intraepithelial Lesions of Cervical Mucosa Cells in a Screening Programme for Cervical Cancer in Isère, France

被引:0
作者
Balamou, Christian [1 ,2 ,3 ]
Zysman, Karine [4 ]
Olicard, Cecile [4 ]
Garnier, Anne [4 ]
Seigneurin, Arnaud [1 ,2 ,5 ]
机构
[1] Univ Grenoble Alpes, Grenoble, France
[2] Translat Innovat Med & Complex, Rech Translat & Innovat Med & Complex UMR 5525 Lab, La Tronche, France
[3] Ctr Reg Coordinat Depistages Canc Auvergne Rhone A, Bourg En Bresse, France
[4] Ctr Reg Coordinat Depistages Canc Auvergne Rhone A, Meylan, France
[5] CHU Grenoble, Registre Canc Isere, Grenoble, France
关键词
cervical cancer screening; cervical pap smear; high-grade intraepithelial lesions; HPV; prevalence; uterine cervical neoplasms; HUMAN-PAPILLOMAVIRUS; WOMEN; GUIDELINES; INFECTION; ISERE; RISK;
D O I
10.1002/cam4.70259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThis study aims to analyse high-grade intraepithelial lesions (LIEHG) observed in a screening programme from 2010 to 2018 to more accurately describe them and formulate recommendations for best practices in the context of screening evolution following the introduction of an HPV test in primary cervical cancer screening in 2020.MethodsThis study included 305,940 asymptomatic women aged 25-65 years. The eligible population was invited to undergo a screening cervico-uterine-smear every 3 years. If this smear was normal, the woman received a new invitation. In the case of a positive screen, the patient underwent further diagnostic procedures, such as colposcopy and biopsy to confirm the diagnosis. Only those diagnosed with LIEHG and above proceeded to treatment. The diagnoses associated with LIEHG were those related to the WHO Classification of tumours of the uterine cervix.ResultsPositive smears led to the diagnosis of 3230 LIEHG. The prevalence of LIEHG in the screened population was 0.4%. The LIEHG distribution varied significantly according to the age of the women. The probability of diagnosing LIEHG in young women was 12.2% at 25-29 years. This probability decreased by half after 50 years. We observed that the type of smear was significantly associated with LIEHG detection. The positive predictive value for diagnosing LIEHG was 70.3% for high-grade squamous intraepithelial lesion (HSIL) smears and 35.1% for atypical squamous cells cannot exclude HSIL (ASC-H) smears.ConclusionIn the study population, the prevalence of LIEHG was high in women under 35 years. Low-grade smears were correlated with the risk of LIEHG and should prompt screening facilities to allocate resources to ensure active follow-up of LSIL and ASC-US smears. Adherence to cytological screening recommendations was associated with a reduced risk of LIEHG in multivariate analysis. At the time of the data extraction 732,203 cervico-uterine-smears had been performed on 305,940 women. The number of first positive smear observed in each woman was retained in the analysis: 31,097 cases. These positive smears led to the diagnosis of 3,230 LIEHG.image
引用
收藏
页数:13
相关论文
共 37 条
[1]  
Abdul-Karim F.W., 2015, BETHESDA SYSTEM REPO, P103
[2]   Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer [J].
Amin, Fatema Alzahraa Samy ;
Naher, Zeba Un ;
Ali, P. Shaik Syed .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) :8077-8086
[3]   Social Inequalities in Participation in Cervical Cancer Screening in a Metropolitan Area Implementing a Pilot Organised Screening Programme (Paris Region, France) [J].
Audiger, Celine ;
Bovagnet, Thomas ;
Bardes, Julia ;
Abihsera, Gaelle ;
Nicolet, Jerome ;
Deghaye, Michel ;
Bochaton, Audrey ;
Menvielle, Gwenn .
INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2022, 67
[4]   Factors associated with participation in the organized cervical cancer screening program in the greater Paris area (France): An analysis among more than 200,000 women [J].
Audiger, Celine ;
Bovagnet, Thomas ;
Deghaye, Michel ;
Kaufmanis, Aldis ;
Pelisson, Caroline ;
Bochaton, Audrey ;
Menvielle, Gwenn .
PREVENTIVE MEDICINE, 2021, 153
[5]  
Balamou C., 2023, Cancer Res Stat Treatm, V6, P365, DOI [10.4103/crst.crst3223, DOI 10.4103/CRST.CRST3223]
[6]   Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program [J].
Baldauf, Jean-Jacques ;
Fender, Muriel ;
Bergeron, Christine ;
Marrer, Emilie ;
Velten, Michel ;
Pradat, Pierre ;
Arbyn, Marc .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2019, 28 (01) :33-39
[7]  
Bolla M, 1996, B CANCER, V83, P750
[8]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[9]   Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263
[10]   Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models [J].
Brisson, Marc ;
Benard, Elodie ;
Drolet, Melanie ;
Bogaards, Johannes A. ;
Baussano, Iacopo ;
Vanska, Simopekka ;
Jit, Mark ;
Boily, Marie-Claude ;
Smith, Megan A. ;
Berkhof, Johannes ;
Canfell, Karen ;
Chesson, Harrell W. ;
Burger, Emily A. ;
Choi, Yoon H. ;
De Blasio, Birgitte Freiesleben ;
De Vlas, Sake J. ;
Guzzetta, Giorgio ;
Hontelez, Jan A. C. ;
Horn, Johannes ;
Jepsen, Martin R. ;
Kim, Jane J. ;
Lazzarato, Fulvio ;
Matthijsse, Suzette M. ;
Mikolajczyk, Rafael ;
Pavelyev, Andrew ;
Pillsbury, Matthew ;
Shafer, Leigh Anne ;
Tully, Stephen P. ;
Turner, Hugo C. ;
Usher, Cara ;
Walsh, Cathal .
LANCET PUBLIC HEALTH, 2016, 1 (01) :E8-E17